IHE vs. XLV
IHE (iShares U.S. Pharmaceuticals ETF) and XLV (State Street Health Care Select Sector SPDR ETF) are both Health & Biotech Equities funds - IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index while XLV tracks the Health Care Select Sector Index. Both are passively managed. Over the past 10 years, IHE returned 7.69%/yr vs 9.12%/yr for XLV. Their correlation of 0.86 suggests significant overlap in exposure. IHE charges 0.42%/yr vs 0.08%/yr for XLV.
Performance
IHE vs. XLV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IHE achieves a 5.25% return, which is significantly higher than XLV's -5.04% return. Over the past 10 years, IHE has underperformed XLV with an annualized return of 7.69%, while XLV has yielded a comparatively higher 9.12% annualized return.
IHE
- 1D
- -1.44%
- 1M
- 1.13%
- YTD
- 5.25%
- 6M
- 7.86%
- 1Y
- 38.69%
- 3Y*
- 17.02%
- 5Y*
- 9.73%
- 10Y*
- 7.69%
XLV
- 1D
- -0.97%
- 1M
- 0.85%
- YTD
- -5.04%
- 6M
- -4.36%
- 1Y
- 12.27%
- 3Y*
- 5.70%
- 5Y*
- 5.45%
- 10Y*
- 9.12%
IHE vs. XLV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 5.25% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
XLV State Street Health Care Select Sector SPDR ETF | -5.04% | 14.50% | 2.47% | 2.07% | -2.08% | 26.04% | 13.30% | 20.45% | 6.28% | 21.77% |
Correlation
The correlation between IHE and XLV is 0.85, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.85 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.83 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.84 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.84 |
Correlation (All Time) Calculated using the full available price history since May 8, 2006 | 0.86 |
The correlation between IHE and XLV has been stable across timeframes, ranging from 0.83 to 0.86 - a consistent structural relationship.
IHE vs. XLV - Sectors Allocation Comparison
Sectors
IHE
XLV
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IHE
XLV
Basic Materials
IHE
-
XLV
-
Communication Services
IHE
-
XLV
-
Consumer Cyclical
IHE
-
XLV
-
Consumer Defensive
IHE
-
XLV
-
Energy
IHE
-
XLV
-
Financial Services
IHE
-
XLV
-
Industrials
IHE
-
XLV
-
Real Estate
IHE
-
XLV
-
Technology
IHE
-
XLV
-
Utilities
IHE
-
XLV
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IHE vs. XLV — Risk / Return Rank
IHE
XLV
IHE vs. XLV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and State Street Health Care Select Sector SPDR ETF (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IHE | XLV | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.28 | 0.84 | +1.44 |
Sortino ratioReturn per unit of downside risk | 3.33 | 1.36 | +1.97 |
Omega ratioGain probability vs. loss probability | 1.39 | 1.15 | +0.24 |
Calmar ratioReturn relative to maximum drawdown | 4.65 | 1.18 | +3.47 |
Martin ratioReturn relative to average drawdown | 14.05 | 2.87 | +11.18 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IHE | XLV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.28 | 0.84 | +1.44 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.60 | 0.37 | +0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.43 | 0.55 | -0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.50 | 0.46 | +0.05 |
Drawdowns
IHE vs. XLV - Drawdown Comparison
The maximum IHE drawdown since its inception was -38.20%, roughly equal to the maximum XLV drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for IHE and XLV.
Loading charts...
Drawdown Indicators
| IHE | XLV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.20% | -39.17% | +0.97% |
Max Drawdown (1Y)Largest decline over 1 year | -8.47% | -10.47% | +2.00% |
Max Drawdown (3Y)Largest decline over 3 years | -15.92% | -17.11% | +1.19% |
Max Drawdown (5Y)Largest decline over 5 years | -16.03% | -17.11% | +1.08% |
Max Drawdown (10Y)Largest decline over 10 years | -29.59% | -28.40% | -1.19% |
Current DrawdownCurrent decline from peak | -3.91% | -8.24% | +4.33% |
Average DrawdownAverage peak-to-trough decline | -7.92% | -7.12% | -0.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.80% | 4.30% | -1.50% |
Volatility
IHE vs. XLV - Volatility Comparison
iShares U.S. Pharmaceuticals ETF (IHE) has a higher volatility of 5.43% compared to State Street Health Care Select Sector SPDR ETF (XLV) at 4.05%. This indicates that IHE's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IHE | XLV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.43% | 4.05% | +1.38% |
Volatility (6M)Calculated over the trailing 6-month period | 12.51% | 10.32% | +2.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.05% | 14.65% | +2.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.23% | 14.69% | +1.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.05% | 16.55% | +1.50% |
IHE vs. XLV - Expense Ratio Comparison
IHE has a 0.42% expense ratio, which is higher than XLV's 0.08% expense ratio.
Dividends
IHE vs. XLV - Dividend Comparison
IHE's dividend yield for the trailing twelve months is around 1.67%, less than XLV's 1.71% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.67% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
XLV State Street Health Care Select Sector SPDR ETF | 1.71% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
IHE and XLV have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IHE has higher volatility (5.43%) compared to XLV (4.05%). In terms of maximum drawdown, IHE dropped -38.20% vs XLV's -39.17%.
On 10-year performance, XLV leads with 9.12% vs 7.69% for IHE. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 4.05%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XLV has performed better with a 9.12% return vs 7.69%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLV is cheaper with a 0.08% expense ratio, compared with 0.42% for IHE.
XLV has the higher dividend yield at 1.71%, compared with 1.67% for IHE.
IHE tracks Dow Jones U.S. Select Pharmaceuticals Index, while XLV tracks Health Care Select Sector Index. They also come from different issuers: iShares and State Street. Their fees differ too: 0.42% for IHE and 0.08% for XLV.
IHE currently has the higher Sharpe Ratio (2.28 vs 0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IHE and XLV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer